Patent Assignment
Reel/Frame 063518/0458
Assignment of Assignor's Interest
Recorded: 2023-05-03
Pages: 6
Assignor
TABUTEAU, HERRIOT
Executed: 2023-04-28
Assignee
AXSOME THERAPEUTICS, INC.
ONE WORLD TRADE CENTER, 22ND FLOOR, NEW YORK, NEW YORK, 10007
Covered Properties
(9)
Methods of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion
Application:
18/153,950 →
Publication:
US US20240238273A1
Pharmaceutical Compositions Comprising Meloxicam
Microparticles Containing Bupropion
Application:
18/162,259 →
Publication:
US US20240000729A1
Pharmaceutical Compositions Comprising Bupropion and Cysteine
Pharmaceutical Compositions Comprising Meloxicam
Pharmaceutical Compositions Comprising Meloxicam
Methods of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion
Application:
18/299,009 →
Publication:
US US20240358696A1
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
Application:
18/300,318 →
Publication:
US US20230248668A1
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
Application:
18/300,917 →
Publication:
US US20230248669A1
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 17, 2024
From: AXSOME THERAPEUTICS, INC.,
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 069608/0054 →
Security Interest
May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →
Assignment of Assignor's Interest
Jul 25, 2025
From: AXSOME THERAPEUTICS, INC.
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 071835/0738 →
Assignment of Assignor's Interest
Mar 4, 2026
From: AXSOME THERAPEUTICS, INC.
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 073973/0726 →